Proof of principle has been provided by pharmacological experiments showing improvement of anemia following hepcidin neutralization in a rat model of AI, based on injection with group A streptococcal peptidoglycan-polysaccharide (PG-APS) [15,61]. The gene discussed is HAMP; the disease is anemia (phenotype).